FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/10/2025
Voltar para busca
Dado oficial do USPTO
ZORYA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
29
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 9, 42
Data de depósito
26/05/2023
Data de registro
25/02/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
25/02/2025
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
FR
Examinador
REID, CAILE MAUREEN
Unidade examinadora
N50
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of three stacked quadrilaterals creating a stylized design of sun rays, wherein the quadrilaterals are colored orange (cmyk: 0/60/100/0) fading to yellow (cmyk: 0/25/100/0) from left-to-right. This design is to the left of the stylized black wording "ZORYA".
Titulares e representantes
Titulares
CYTOO
Representantes
Steven J. Solomon Tucker Ellis LLP
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical productsnamely pharmaceutical preparations for the prevention and the treatment of muscle dysfunction associated diseasesmuscle dystrophiesmuscle metabolic diseasesmuscle atrophy associated diseasessarcopeniacancercachexiaobesitydiabetes and cardiovascular diseasesrenal diseasesnephropathiesneuropathiesretinopathiesneurodegenerativepsychiatric and cognitive diseasesmetabolic diseasesinflammatory diseases; veterinary productsnamely veterinary preparations for the prevention and the treatment of muscle dysfunction associated diseasesmuscle dystrophiesmuscle metabolic diseasesmuscle atrophy associated diseasessarcopeniacancercachexiaobesitydiabetes and cardiovascular diseasesrenal diseasesnephropathiesneuropathiesretinopathiesneurodegenerativepsychiatric and cognitive diseasesmetabolic diseasesinflammatory diseases; sanitary preparations for medical use; chemical and biological preparations for medical usenamely pharmaceutical preparations for the prevention and the treatment of muscle dysfunction associated diseasesmuscle dystrophiesmuscle metabolic diseasesmuscle atrophy associated diseasessarcopeniacancercachexiaobesitydiabetes and cardiovascular diseasesrenal diseasesnephropathiesneuropathiesretinopathiesneurodegenerativepsychiatric and cognitive diseasesmetabolic diseasesinflammatory diseases; chemical and biological preparations for pharmaceutical use for the prevention and the treatment of muscle dysfunction associated diseasesmuscle dystrophiesmuscle metabolic diseasesmuscle atrophy associated diseasessarcopeniacancercachexiaobesitydiabetes and cardiovascular diseasesrenal diseasesnephropathiesneuropathiesretinopathiesneurodegenerativepsychiatric and cognitive diseasesmetabolic diseasesinflammatory diseasesbiological preparations for pharmaceutical use being biological preparations for use in cell cultures for medical purposes
Classe 9
Quality control and testing devices namely culture plates to test and conduct quality control in the field of biologybiotechnology and pharmacy; downloadable software for the collectionprocessing and analysis of data in the field of biotechnology and pharmacy; scientific laboratory instrumentsnamely computer hardware and downloadable software for data analysisdatabase managementdata processingin the field of life science research and the pharmaceutical industry market and diagnostics
Classe 42
Medicalbiotechnologicalpharmaceutical research; research and development of chemicalbiological and scientific products and materials in the biologicalbiotechnologicalmedicaldiagnostic and pharmaceutical fields; scientific researchadvisory and information services in the medicalbiotechnologicalpharmaceuticaldiagnostictechnological and industrial fields; design and development of computerssoftware and computer platforms; technical testing namely technological testing in the scientificbiologicalbiotechnological and medical fields and quality control services of goods and services; advisory services with respect to quality testingtechnical testing namelytechnological testing in the scientificbiologicalbiotechnological and medical fieldsscientific research advisory services with respect to scientific and medical clinical trials; services for scientific development and analysis of cell tests; scientific and medical research and development of products and services in the field of imagingin the scientificbiologicalbiochemicalmolecular-biologybiotechnological and medical fields; Scientific interpretation and analysis of data by imaging in the scientificbiologicalbiochemicalmolecular-biologybiotechnological and medical fields; diagnostic and industrial research in the biologicalbiotechnological and medical fields
Publicações
Histórico de despachos e eventos da marca no USPTO.
29 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/09/2025
FIMP
FINAL DISPOSITION PROCESSED
11/09/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
25/05/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
19/04/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
31/03/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
31/03/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
25/02/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
25/02/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/01/2025
PUBO
PUBLISHED FOR OPPOSITION
07/01/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/01/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/10/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
22/10/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
22/10/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
22/10/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
22/10/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/09/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/09/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/09/2024
RFNT
REFUSAL PROCESSED BY IB
16/04/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
25/03/2024
RFRR
REFUSAL PROCESSED BY MPU
25/03/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/03/2024
CNRT
NON-FINAL ACTION WRITTEN
01/03/2024
DOCK
ASSIGNED TO EXAMINER
20/02/2024
MAFR
APPLICATION FILING RECEIPT MAILED
07/11/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/11/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/11/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ZORYA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.